NANOTETRAC

Pharmaceutical agents and preparations affecting macular degeneration, solid tumors, hematologic malignancies, ocular disorders, angiogenesis, arthritis, dermatology, digestive organs, metabolism, peripheral nervous system, sensory organs, central nervous system, hormonal disorders, diabetes, eye diseases and conditions, heart disorders, joint disease, cancer and the prevention and treatment of cancer, hyperthyroidism, Alzheimer's disease, respiratory diseases, chemotherapy and radioactive in vivo diagnostic or therapeutic use; radioactive pharmaceutical preparations for use in vivo diagnostic use; appetite suppressants; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based injectable, eye drop or oral delivery tablets or capsules for the continuous release of a wide variety of therapeutic agents; pharmaceutical skin lotion, cream, ointment, and skin patch

Drug delivery systems consisting of polymer-based injectable, eye drop or oral delivery devices for the continuous release of a wide variety of therapeutic agents